Plain-English translation of NCT07629609 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a new imaging scan called Total Body PET/CT to see if it can better detect when pancreatic cancer or gastroesophageal cancer (cancer of the stomach or lower esophagus) has spread to other parts of the body. The researchers want to know if this new scan is more accurate than standard imaging and whether it can produce clear pictures in less than 30 minutes, which could help doctors plan surgery or treatment more effectively.
Current imaging methods sometimes miss signs that cancer has spread beyond the original tumor, which can affect treatment decisions and surgical planning. This trial exists to see whether the new scanning method can detect cancer spread more reliably and quickly, potentially improving outcomes for patients with these types of cancer.
You likely qualify if…
You likely don't qualify if…
Depending on which group you join, you will have one or two specialized imaging scans before your surgery, diagnostic procedure, or chemotherapy treatment. Some participants will also have a second scan during chemotherapy treatment. You will complete a brief questionnaire and then be followed by the research team for one year after your scans to see how your cancer progresses and how well the new imaging method predicted your outcome.
AI-generated summary from trial data · Jun 18, 2026 · Not medical advice
Denmark